Healthcare

CytoDyn (OTC: CYDY) Abstract by Dr. Jonah Sacha for Use of Leronlimab as PrEP is Accepted by the Keystone Symposia on HIV Pathogenesis and Cure

VANCOUVER, Washington, Jan 27, 2020 — The poster and oral presentation will highlight the role of the CCR5 antibody in preventing macaques from intrarectal Simian-Human Immunodeficiency Virus (SHIV) Based on these strong results, CytoDyn has […]

No Picture
Trading Ideas

Analysts: 2 Big 8% Dividend Stocks to Buy (And 1 to Sell)

We’re coming off a year of major-league gains in the markets, and analysts are predicting a flatter year ahead. With the strong likelihood that share price returns will slow down, now is a logical time to start reassessing your portfolio. It’s time to decide which stocks to shed, and which to snap up.Income is the deciding factor. Investing is all about making money, making your investments grow. So, if markets follow the predictions, and growth slows, that leaves dividends as the sensible route to go. Dividends provide a steady income stream, whether markets go up or down. But not all …read more […]

No Picture
Trading Ideas

J&J CEO to testify at trial for first time on Baby Powder risks

Johnson & Johnson Chief Executive Officer Alex Gorsky was set to be called as a witness on Monday in what would be his first appearance in a jury trial over allegations that the company’s Baby Powder causes cancer. Lawyers for three men and one woman who sued J&J subpoenaed Gorsky in a trial playing out in a state courtroom in New Brunswick, New Jersey near the company’s headquarters. All four have mesothelioma, a rare and incurable cancer that they said was caused by their exposure to asbestos in Baby Powder applied when they were diapered as infants. …read more […]

No Picture
Trading Ideas

Sprint loses fewer subscribers than expected on cheaper phone plans

The company said it lost 115,000 postpaid phone subscribers during the quarter ended Dec 31. Analysts were expecting a net loss of 160,000 subscribers, according to research firm FactSet. Sprint, the fourth largest U.S. wireless carrier by subscribers, is facing a multi-state lawsuit against its $26-billion proposed merger with larger rival T-Mobile US Inc. …read more […]